Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, July 30, 2024
[ Tue, Jul 30th 2024
] - WOPRAI
[ Tue, Jul 30th 2024
] - WOPRAI
[ Tue, Jul 30th 2024
] - WOPRAI
[ Tue, Jul 30th 2024
] - WOPRAI
[ Tue, Jul 30th 2024
] - WOPRAI
[ Tue, Jul 30th 2024
] - WOPRAI
[ Tue, Jul 30th 2024
] - WOPRAI
[ Tue, Jul 30th 2024
] - WOPRAI
[ Tue, Jul 30th 2024
] - WOPRAI
[ Tue, Jul 30th 2024
] - WOPRAI
[ Tue, Jul 30th 2024
] - WOPRAI
[ Tue, Jul 30th 2024
] - WOPRAI
[ Tue, Jul 30th 2024
] - WOPRAI
[ Tue, Jul 30th 2024
] - WOPRAI
[ Tue, Jul 30th 2024
] - WOPRAI
[ Tue, Jul 30th 2024
] - WOPRAI
[ Tue, Jul 30th 2024
] - WOPRAI
[ Tue, Jul 30th 2024
] - WOPRAI
[ Tue, Jul 30th 2024
] - WOPRAI
[ Tue, Jul 30th 2024
] - WOPRAI
[ Tue, Jul 30th 2024
] - WOPRAI
[ Tue, Jul 30th 2024
] - WOPRAI
[ Tue, Jul 30th 2024
] - WOPRAI
[ Tue, Jul 30th 2024
] - WOPRAI
[ Tue, Jul 30th 2024
] - WOPRAI
[ Tue, Jul 30th 2024
] - WOPRAI
[ Tue, Jul 30th 2024
] - WOPRAI
Jason Zemansky Maintained (SNDX) at Strong Buy with Decreased Target to $30 on, Jul 30th, 2024
Jason Zemansky of B of A Securities, Maintained "Syndax Pharmaceuticals, Inc." (SNDX) at Strong Buy with Decreased Target from $31 to $30 on, Jul 30th, 2024.
Jason has made no other calls on SNDX in the last 4 months.
There are 5 other peers that have a rating on SNDX. Out of the 5 peers that are also analyzing SNDX, 0 agree with Jason's Rating of Hold.
These are the ratings of the 5 analyists that currently disagree with Jason
- Edward White of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $41 on, Monday, July 29th, 2024
- Kelly Shi of "Jefferies" Initiated at Strong Buy and Held Target at $37 on, Friday, June 28th, 2024
- Bradley Canino of "Stifel" Maintained at Strong Buy with Increased Target to $42 on, Wednesday, June 26th, 2024
- Anupam Rama of "JP Morgan" Maintained at Buy and Held Target at $34 on, Tuesday, May 21st, 2024
- Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $30 on, Thursday, May 9th, 2024
